ATR inhibitors synergize with mitomycin C to enhance cytotoxicity in patient-derived non-muscle invasive bladder cancer organoids
Alba Zuidema, Levi Nijland, Mette Marit Vosjan, Kyah van Megesen, Bastiaan J. Viergever, Onno Kranenburg, Richard Paul Meijer
This study shows that combining ATR inhibitors with mitomycin C significantly reduces viability of NMIBC organoids compared to chemotherapy or ATR inhibitors alone.
bioRxiv · Aug 29, 2025 · PreprintCancer Biology